Results 91 to 100 of about 20,954 (250)

Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study

open access: yesColorectal Disease, Volume 27, Issue 10, October 2025.
Abstract Aim Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment for peritoneal metastases (PM) of colorectal or appendiceal origin. Rectal anastomotic leakage (RAL) or rectal stump blow‐out is a serious complication following rectal resection after CRS‐HIPEC. This study aimed to compare outcomes
Lana Ghanipour   +4 more
wiley   +1 more source

Mucocele of Appendix

open access: yesIndian Journal of Colo-Rectal Surgery, 2023
Mucocele of the appendix is rare and does not have a specific clinical presentation, and hence, preoperative diagnosis is difficult, but it is important to plan the right surgery to avoid morbidity and mortality secondary to pseudomyxoma peritonei.
Sunilkumar B. Alur   +3 more
doaj   +1 more source

Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review

open access: yesClinics, 2022
Highlights • Hyperthermia chemotherapy and cytoreductive surgery in patients with peritoneal pseudomyxoma.
I. Floriano   +4 more
semanticscholar   +1 more source

Atypical Presentation of Metastasis of Appendiceal Cancer: Neoplastic Growth Infiltrating an Inguinal Hernia

open access: yesClinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Although rare, appendiceal cancer can metastasize to unusual sites, including the inguinal canal. In patients with a history of abdominal malignancy presenting with an inguinal hernia, metastatic disease should be considered for adequate recognition and early oncologic intervention.
Peter Mounas   +3 more
wiley   +1 more source

Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study [PDF]

open access: yes, 2010
Background Mitomycin C is a chemotherapeutic agent used in the treatment of peritoneal surface malignancies, administered as hyperthermic intraperitoneal chemotherapy after cytoreductive surgery. Pharmacokinetic studies have been based on
Olaf Sørensen   +6 more
core   +2 more sources

Nomogram to predict overall survival of patients with pseudomyxoma peritonei of appendiceal origin: A retrospective cohort study

open access: yesJournal of Surgical Oncology, 2021
Pseudomyxoma peritonei (PMP) is a rare disease, with the rate of overall survival (OS) influenced by many factors. The present study aimed to define independent predictors and establish a nomogram for individual risk prediction in PMP patients.
Mingjian Bai   +8 more
semanticscholar   +1 more source

Mucocele of the Appendix Secondary to Chronic Appendicitis: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT Chronic appendicitis leading to mucocele of appendix, though rare and often mimicking malignancy, can present with benign histopathology. Multidisciplinary correlation of clinical, imaging, intraoperative, and histopathological findings is critical to avoid misdiagnosis and guide conservative management in atypical presentations.
Parvat Kuwar Chhetri   +2 more
wiley   +1 more source

Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review

open access: yesPleura and Peritoneum, 2023
The Peritoneal Surface Oncology Group International (PSOGI) consensus subdivided pseudomyxoma peritonei (PMP) into four groups according to histopathological features. The aim of this paper is to report survival outcomes after cytoreductive surgery (CRS)
Martín-Román Lorena   +7 more
doaj   +1 more source

Abnormal DNA Methylation Profile Suggests the Extension of the Clinical Spectrum of the SETD2 ‐Related Disorders to a Syndromic Multiple Tumor Phenotype

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 7, July 2025.
ABSTRACT SETD2 has an essential role in epigenetic regulation. SETD2 pathogenic variants cause neurodevelopmental disorders (SETD2‐NDDs) that most commonly include various degrees of intellectual disability and behavioral disorders, macrocephaly, brain malformations, and generalized overgrowth.
Marie Lucain   +11 more
wiley   +1 more source

Reg IV in human body and diseases [PDF]

open access: yes, 2012
Inflammatory bowel diseases (IBD) and cancers of the gastrointestinal (GI) tract cause considerable morbidity and mortality. In order to enhance the diagnostics and therapeutic measures, the biology of these diseases needs to be better understood ...
Maille, Kukka
core  

Home - About - Disclaimer - Privacy